Lipodystrophy: Syndrome of severe insulin resistance

References

• Gregoire FM . Adipocyte differentiation: from fibroblast to endocrine cell. Exp Biol Med 2001;226:997.
   PubMed Web of Science ®Google Scholar
• Smith J , Al-Amri M , Dorairaj P , Sniderman A . The adipocyte life cycle hypothesis. Clin Sci 2006;110:1–9.
   PubMed Web of Science ®Google Scholar
• Yang X , Jansson PA , Nagaev I , et al. Evidence of impaired adipogenesis in insulin resistance. Biochem Biophys Res Commun 2004;317:1045–51.
   PubMed Web of Science ®Google Scholar
• Hegele RA . Insulin resistance in human partial lipodystrophy. Curr Atheroscler Rep 2000;2:397–404.
   PubMedGoogle Scholar
• Kershaw E , Flier J . Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548–56.
   PubMed Web of Science ®Google Scholar
• Galic S , Oakhill JS , Steinberg GR . Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010;316:129–39.
   PubMed Web of Science ®Google Scholar
• Huang-Doran I , Sleigh A , Rochford JJ , et al. Lipodystrophy: metabolic insights from a rare disorder. J Endocrinol 2010;207:245–55.
   PubMed Web of Science ®Google Scholar
• Giralt M , Díaz-Delfín J , Gallego-Escuredo JM , et al. Lipotoxicity on the basis of metabolic syndrome and lipodystrophy in HIV-1-infected patients under antiretroviral treatment. Curr Pharm Des 2010;16:3371–8.
   PubMed Web of Science ®Google Scholar
• Agarwal AK , Simha V , Oral EA , Moran SA . Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocrinol Metab 2003;88:4840–7.
   PubMed Web of Science ®Google Scholar
• Novelli G , Muchir A , Sangiuolo F , Helbling-Leclerc A . Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am J Hum Genet 2002;71:426–31.
   PubMed Web of Science ®Google Scholar
• Hegele RA , Cao H , Anderson CM , Hramiak I . Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy. J Clin Endocrinol Metab 2000;85:3431–5.
   PubMed Web of Science ®Google Scholar
• Dechat T , Pfleghaar K , Sengupta K , et al. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev 2008;22:832–53.
   PubMed Web of Science ®Google Scholar
• Dunnigan MG , Cochrane M , Kelly A , Scott JW . Familial lipoatrophic diabetes with dominant transmission: a new syndrome. Q J Med 1974;43:33–48.
   PubMedGoogle Scholar
• Cao H , Hegele RA . Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 2000;9:109–12.
   PubMed Web of Science ®Google Scholar
• Desvergne B , Wahli W . Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999;20:649–88.
   PubMed Web of Science ®Google Scholar
• Chen D , Misra A , Garg A . Clinical review 153: lipodystrophy in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab 2002;87:4845–56.
   PubMed Web of Science ®Google Scholar
• Estrada V , Serrano-Ríos M , Martínez Larrad MT , et al. Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy. J Acquir Immune Defic Syndr 2002;29:32–40.
   PubMed Web of Science ®Google Scholar
• Li E , Norris AW . Structure/function of cytoplasmic vitamin A-binding proteins. Annu Rev Nutr 1996;16:205–34.
   PubMed Web of Science ®Google Scholar
• Misra A , Garg A . Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature. Medicine 2003;82:129–46.
   PubMed Web of Science ®Google Scholar
• Dinauer PA , Brixey CJ , Moncur JT , et al. Pathologic and MR imaging features of benign fibrous soft-tissue tumors in adults. Radiographics 2007;27:173–87.
   PubMed Web of Science ®Google Scholar
• Wilson DE , Chan IF , Stevenson KB , et al. Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance. J Clin Endocrinol Metab 1983;57:517–23.
   PubMed Web of Science ®Google Scholar
• Moon HS , Dalamaga M , Kim SY . Leptin’s role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr Rev 2013;34:377–412.
   PubMed Web of Science ®Google Scholar
• Safar Zadeh E , Lungu AO , Cochran EK , et al. The liver diseases of lipodystrophy: the long-term effect of leptin treatment. J Hepatol 2013;59:131–7.
   PubMed Web of Science ®Google Scholar
• Tungsiripat M , Bejjani DE , Rizk N . Rosiglitazone improves lipoatrophy in patients receiving thymidine-sparing regimens. AIDS 2010;24:1291–8.
   PubMed Web of Science ®Google Scholar
• Oriot P , Hermans MP , Selvais P , et al. Exenatide improves weight loss insulin sensitivity and beta-cell function following administration to a type 2 diabetic HIV patient on antiretroviral therapy. Ann Endocrinol (Paris) 2011;72:244–6.
   PubMed Web of Science ®Google Scholar
• Falutz J , Mamputu JC , Potvin D , et al. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data. J Clin Endocrinol Metab 2010;95:4291–304.
   PubMed Web of Science ®Google Scholar
• Falutz J , Potvin D , Mamputu JC , et al. A growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension. J Acquir Immune Defic Syndr 2010;53:311–22.
   PubMed Web of Science ®Google Scholar
• Garg A . Lipodystrophies: Genetic and acquired body fat disorders. JCEM 2011;96:3313–25.
   PubMed Web of Science ®Google Scholar